Trial Profile
Usefulness of sitagliptin for type 2 diabetes patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- 14 Jun 2011 New trial record